Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories.
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis.
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.
Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b.
Drugs@FDA (Enter "glatiramer acetate" in search box.)
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
Risks of immune system treatments.
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Estrogen treatment in multiple sclerosis.
Rapid exacerbation of neuromyelitis optica after rituximab treatment.
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity.
FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis.
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
Autoimmunity in visual loss.
Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients.
Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision
Oligodendroglial membrane dynamics in relation to myelin biogenesis.

Pages